Study on the Mechanism of Buyang Huanwu Decoction in Treating Ischemic Stroke by Regulating the NLRP3/Caspase-1 Signaling Pathway

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-04-01
DOI
https://doi.org/10.3390/ph19040567
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study on the Mechanism of Buyang Huanwu Decoction in Treating Ischemic Stroke by Regulating the NLRP3/Caspase-1 Signaling Pathway

Keqi Zeng, Cong Nie, Die Pei, Yingfeng Zhang et al.
Pharmaceuticals
Inflammasome and immune disorders
article

Study on the Mechanism of Buyang Huanwu Decoction in Treating Ischemic Stroke by Regulating the NLRP3/Caspase-1 Signaling Pathway

Keqi Zeng, Cong Nie, Die Pei, Yingfeng Zhang, Xin Zhou
article en

Abstract

No abstract available for this paper.
PharmaceuticalsVol. 19(4)
Guangzhou University of Chinese Medicine (CN)
Guangzhou University of Chinese Medicine, Guangzhou University
Openalex Percentile: Top 34%
Inflammasome and immune disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Study on the Mechanism of Buyang Huanwu Decoction in Treating Ischemic Stroke by Regulating the NLRP3/Caspase-1 Signaling Pathway — Keqi Zeng, Cong Nie, et al. · Pharmaceuticals (2026) | TGRS Research Map | TGRS